{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:26Z","timestamp":1787507126286,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/md.0b013e3181c2af86","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T03:17:47Z","timestamp":1257563867000},"page":"331-340","source":"Crossref","is-referenced-by-count":39,"title":["Clinical and Serologic Baseline and Follow-Up Features of Syphilis According to HIV Status in the Post-HAART Era"],"prefix":"10.1097","volume":"88","author":[{"given":"David","family":"Farhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadjet","family":"Benhaddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Zizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Deleuze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Krivine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210309","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/319591","article-title":"Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children.","volume":"32","author":"Berkelhamer","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R2-3-20210309","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJM198706183162507","article-title":"Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection.","volume":"316","author":"Berry","year":"1987","journal-title":"N Engl J Med"},{"key":"R4-3-20210309","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(89)90589-8","article-title":"Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men.","volume":"2","author":"Cameron","year":"1989","journal-title":"Lancet"},{"key":"R5-3-20210309","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.olq.0000162359.75509.9c","article-title":"Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002.","volume":"32","author":"Chesson","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R6-3-20210309","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2105\/AJPH.77.4.479","article-title":"Risk factors for human immunodeficiency virus (HIV) infections in homosexual men.","volume":"77","author":"Darrow","year":"1987","journal-title":"Am J Public Health"},{"key":"R8-3-20210309","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00007435-197707000-00005","article-title":"Treatment of secondary syphilis: an evaluation of 204 patients.","volume":"4","author":"Fiumara","year":"1977","journal-title":"Sex Transm Dis"},{"key":"R9-3-20210309","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00007435-197707000-00004","article-title":"Treatment of seropositive primary syphilis: an evaluation of 196 patients.","volume":"4","author":"Fiumara","year":"1977","journal-title":"Sex Transm Dis"},{"key":"R10-3-20210309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"R11-3-20210309","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00042560-199807010-00012","article-title":"HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India.","volume":"18","author":"Gadkari","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R12-3-20210309","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/sti.2006.021402","article-title":"Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics.","volume":"83","author":"Ghanem","year":"2007","journal-title":"Sex Transm Infect"},{"key":"R13-3-20210309","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1086\/589295","article-title":"Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.","volume":"47","author":"Ghanem","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R14-3-20210309","first-page":"275","article-title":"Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women.","volume":"71","author":"Goeman","year":"1995","journal-title":"Genitourin Med"},{"key":"R15-3-20210309","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/sti.2005.015875","article-title":"Syphilis in adults.","volume":"81","author":"Goh","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"Suppl 3","key":"R16-3-20210309","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/0956462011924065","article-title":"European guideline for the management of syphilis.","volume":"12","author":"Goh","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R17-3-20210309","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.290.11.1510","article-title":"Update on syphilis: resurgence of an old problem.","volume":"290","author":"Golden","year":"2003","journal-title":"JAMA"},{"key":"R18-3-20210309","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-118-5-199303010-00005","article-title":"Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users.","volume":"118","author":"Gourevitch","year":"1993","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"R19-3-20210309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0140-6736(98)90006-X","article-title":"Is elimination of endemic syphilis transmission a realistic goal for the USA?","volume":"351","author":"Hook","year":"1998","journal-title":"Lancet"},{"key":"R20-3-20210309","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-121-2-199407150-00003","article-title":"Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection.","volume":"121","author":"Hutchinson","year":"1994","journal-title":"Ann Intern Med"},{"key":"R21-3-20210309","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000018149","article-title":"A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis.","volume":"198","author":"Janier","year":"1999","journal-title":"Dermatology"},{"key":"R22-3-20210309","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/sti.2003.007179","article-title":"Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals.","volume":"80","author":"Kingston","year":"2004","journal-title":"Sex Transm Infect"},{"key":"R23-3-20210309","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.19.1.29-49.2006","article-title":"Biological basis for syphilis.","volume":"19","author":"Lafond","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 10A","key":"R24-3-20210309","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/j.amjmed.2005.07.024","article-title":"Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.","volume":"118","author":"Laurence","year":"2005","journal-title":"Am J Med"},{"key":"R25-3-20210309","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00128071-200607050-00003","article-title":"Cutaneous manifestations of syphilis: recognition and management.","volume":"7","author":"Lautenschlager","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"R26-3-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.olq.0000204506.06551.5f","article-title":"Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease\/HIV infection in Lima, Peru.","volume":"33","author":"Long","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R27-3-20210309","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1258\/095646207782717018","article-title":"The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients.","volume":"18","author":"Manavi","year":"2007","journal-title":"Int J STD AIDS"},{"key":"R28-3-20210309","first-page":"1","article-title":"The profile of neurosyphilis in Denmark A clinical and serological study of all patients in Denmark with neurosyphilis disclosed in the years 1971-1979 incl. by Wassermann reaction (CWRM) in the cerebrospinal fluid.","volume":"96","author":"Perdrup","year":"1981","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"R29-3-20210309","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archinte.1990.00390180107020","article-title":"The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics.","volume":"150","author":"Quinn","year":"1990","journal-title":"Arch Intern Med"},{"key":"R31-3-20210309","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa044284","article-title":"Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.","volume":"353","author":"Riedner","year":"2005","journal-title":"N Engl J Med"},{"key":"R32-3-20210309","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM199707313370504","article-title":"A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group.","volume":"337","author":"Rolfs","year":"1997","journal-title":"N Engl J Med"},{"key":"R33-3-20210309","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00007435-200103000-00007","article-title":"Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study.","volume":"28","author":"Rompalo","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R34-3-20210309","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007435-200110000-00005","article-title":"A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?","volume":"28","author":"Rottingen","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R35-3-20210309","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00002030-199105000-00020","article-title":"Syphilis treatment response in HIV-infected individuals.","volume":"5","author":"Telzak","year":"1991","journal-title":"Aids"},{"key":"R36-3-20210309","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/515240","article-title":"Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation.","volume":"177","author":"Theus","year":"1998","journal-title":"J Infect Dis"},{"key":"R37-3-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007435-199219020-00001","article-title":"Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.","volume":"19","author":"Wasserheit","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"RR-11","key":"R38-3-20210309","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006.","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R39-3-20210309","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.1996.00440030127015","article-title":"Serologic response to treatment of syphilis in patients with HIV infection.","volume":"156","author":"Yinnon","year":"1996","journal-title":"Arch Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181c2af86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:03:33Z","timestamp":1786039413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200911000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181c2af86","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}